Drug Resistance in Bacteria, Fungi, Malaria, and Cancer (eBook)

eBook Download: PDF
2017 | 1st ed. 2017
XIV, 630 Seiten
Springer International Publishing (Verlag)
978-3-319-48683-3 (ISBN)

Lese- und Medienproben

Drug Resistance in Bacteria, Fungi, Malaria, and Cancer -
Systemvoraussetzungen
149,79 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
This book is a compilation of past and recent knowledge in the field of emerging drug resistance. The book covers major aspects of drug resistance in bacteria, fungi, malaria, and cancer.
Human survival on earth is constantly threatened by disease and syndrome. From the early days, the aim of research in medicine was to find therapeutic agents that can improve the quality of human life. Although humans are dependent on natural compounds from early days their dependence of drugs increased excessively in last century. The advances in chemistry and biology have helped researchers to identify the drugs that have improved treatment of many diseases. The primary factor for treatment of these diseases is dependent on the efficacy of drugs available. The development of resistance to these drugs is one of the major hindrances. Although there are number of books available on this topic, 'drug resistance' biology across kingdoms has never been discussed in a coherent way.


Dr. Vipin Chandra Kalia is presently working as Chief Scientist, and is the Deputy Director, at Microbial Biotechnology and Genomics, CSIR-Institute of Genomics and Integrative Biology, Delhi. He is a Professor, AcSIR, who obtained his M.Sc. and Ph.D. in Genetics, from Indian Agricultural Research Institute, New Delhi. He has been elected as: (1) Fellow of the National Academy of Sciences (FNASc), (2) Fellow of the National Academy of Agricultural Sciences (FNAAS), and (3) Fellow of the Association of Microbiologists of India (FAMI). His main areas of research are Microbial biodiversity, Bioenergy, Biopolymers, Genomics, Microbial evolution, Quorum sensing, Quorum quenching, Drug discovery and Antimicrobials. He has published 99 papers in Scientific journals such as (1) Nature Biotechnology, (2) Biotechnology Advances, (3) Trends in Biotechnology, (4) Annual Review of Microbiology, (5) Critical Reviews in Microbiology, (6) Bioresource Technology, (7) PLoS ONE, (8) BMC Genomics, (9) International Journal of Hydrogen Energy, and (10) Gene. He has authored 14 book chapters. His works have been cited 3267 times with an h index of 31 and an i10 index of 59. He has Edited 3 books: (i) Quorum Sensing vs Quorum Quenching: A Battle with No End in Sight (2015), (ii) Microbial Factories   Vol.  1: Biofuels, Waste treatment (2015) and (iii) Microbial Factories   Vol. 2:  Biodiversity, Biopolymers, Bioactive Molecules (2015). He is presently the Editor-in-Chief of the Indian Journal of Microbiology and editor of: (1) Journal of Microbiology & Biotechnology (Korea), (2) International Scholarly Res. Network Renewable Energy, (3) Dataset Papers in Microbiology, and (4) PLoS ONE. He is a life member of the following Scientific societies: (1) Society of Biological Chemists of India (2) Society for Plant Biochemistry and Biotechnology, India; (3) Association of Microbiologists of India; (4) Indian Science Congress Association; (5) BioEnergy Society of India, and (6) the Biotech Research Society of India (BRSI). He is also a member of the American Society for Microbiology.

Dr. Vipin Chandra Kalia is presently working as Chief Scientist, and is the Deputy Director, at Microbial Biotechnology and Genomics, CSIR-Institute of Genomics and Integrative Biology, Delhi. He is a Professor, AcSIR, who obtained his M.Sc. and Ph.D. in Genetics, from Indian Agricultural Research Institute, New Delhi. He has been elected as: (1) Fellow of the National Academy of Sciences (FNASc), (2) Fellow of the National Academy of Agricultural Sciences (FNAAS), and (3) Fellow of the Association of Microbiologists of India (FAMI). His main areas of research are Microbial biodiversity, Bioenergy, Biopolymers, Genomics, Microbial evolution, Quorum sensing, Quorum quenching, Drug discovery and Antimicrobials. He has published 99 papers in Scientific journals such as (1) Nature Biotechnology, (2) Biotechnology Advances, (3) Trends in Biotechnology, (4) Annual Review of Microbiology, (5) Critical Reviews in Microbiology, (6) Bioresource Technology, (7) PLoS ONE, (8) BMC Genomics, (9) International Journal of Hydrogen Energy, and (10) Gene. He has authored 14 book chapters. His works have been cited 3267 times with an h index of 31 and an i10 index of 59. He has Edited 3 books: (i) Quorum Sensing vs Quorum Quenching: A Battle with No End in Sight (2015), (ii) Microbial Factories   Vol.  1: Biofuels, Waste treatment (2015) and (iii) Microbial Factories   Vol. 2:  Biodiversity, Biopolymers, Bioactive Molecules (2015). He is presently the Editor-in-Chief of the Indian Journal of Microbiology and editor of: (1) Journal of Microbiology & Biotechnology (Korea), (2) International Scholarly Res. Network Renewable Energy, (3) Dataset Papers in Microbiology, and (4) PLoS ONE. He is a life member of the following Scientific societies: (1) Society of Biological Chemists of India (2) Society for Plant Biochemistry and Biotechnology, India; (3) Association of Microbiologists of India; (4) Indian Science Congress Association; (5) BioEnergy Society of India, and (6) the Biotech Research Society of India (BRSI). He is also a member of the American Society for Microbiology.

Emerging themes in drug resistanceGunjan Arora, Ankur Kulshreshtha, Kriti Arora, Puneet Talwar, Rishi Raj, Gurpreet Grewal, Ritushree Kukreti, Andaleeb Sajid   Molecular Mechanism of Drug Resistance: Common ThemesC. M. Santosh KumarDiversity and evolution of microbial drug resistanceShilpa Ray, Susmita Das, Mrutyunjay SuarFunctional Roles of Highly Conserved Amino Acid Sequence Motifs A and C in Solute Transporters of the Major Facilitator SuperfamilyPrathusha Kakarla, Ranjana KC, Ugina Shrestha, Indrika Ranaweera, Mun Mun Mukherjee, T. Mark Willmon, Alberto J. Hernandez, Sharla R. Barr, and Manuel F. VarelaHow pathogens survive drug pressure?Brijendra Kumar Tiwari*, Gunjan Kak, Deepika Sharma, Krishnamurthy NatarajanFunctional diversity and applications of mobile group II intronsBhagwan Rekadwad, Juan M Gonzalez, and Chandrahasya N. KhobragadeBacterial resistance against antibioticsAnil Kumar and Nikita Chordia   Drug-resistant tuberculosisLili Liang, Yun Ma, Xin liu, Yamin LvEmergence of drug resistance in Mycobacterium and other bacterial pathogens - the post translational modification perspectiveManu Kandpal, Suruchi Aggarwal, Shilpa Jamwal, Amit Kumar YadavGlycogen as Key Energy Storehouse and Possibly Responsible for Multi-Drug Resistance in Mycobacterium Tuberculosis Anil Kumar Gupta, Amit Singh, Sarman SinghRole of external and environmental factors in drug resistance emergence: gut microbiotaDaniel Ryan, Sangeeta Jaiswal, Mrutyunjay SuarEfflux mediated drug resistance in Staphylococcus aureusNitin Pal KaliaTackling the Antibiotic Resistance: The “Gut” FeelingRicha Misra, Abhijit Maji, Richa Virmani, and Darshan Dhakan In silico analytical tools for Phylogenetic and Functional Bacterial GenomicsVipin Chandra Kalia*, Ravi Kumar, Shikha KoulExploiting bacterial genomes to develop biomarkers for identification Ravi Kumar, Shikha Koul, Vipin Chandra KaliaHuman Fungal Pathogens and Drug Resistance Against Azole DrugsPreetida J. Bhetariya, Neha Sharma, Pragati Singh, Priyanka Tripathi, Santosh K. Upadhyay, and Poonam GautamDrug Resistance in MalariaC. M. Santosh KumarDrug Resistance in CancerSantosh K. Upadhyay, Ramesh C. Rai, Rekha Gehtori, Ashutosh Paliwal, Poonam Gautam, and Penny JoshiBCL2 Family Proteins and Other Role in Cancer ResistanceHamida Thakur and Abid R. MattooPerturbed signaling and role of post translational modifications in cancer drug resistanceSuruchi Aggarwal, Manu Kandpal, Shailendra Asthana, Amit Kumar YadavOvarian Cancer and Resistance to Therapies: Clinical and Laboratory PerspectivesRiyaz Basha, Zainab Mohiuddin, Abdul Rahim, Sarfraz AhmadInitiatives across countries to reduce antibiotic utilization and resistance patterns; impact and implicationsBrian Godman, Joseph Fadare, Dan Kibuule, Lyna Irawati, Mwangana Mubita, OlayinkaOgunleye, Margaret Oluka, Bene D Anand Paramadhas, Juliana de Oliveira Costa, Lívia Lovato Pires de Lemos, Augusto Afonso Guerra Júnior, Alian A Alrasheedy, Mohamed Azmi Hassali, Fahad Saleem, Thu Huong, and Ilse TruterIn silico approaches towards combating antibiotic resistanceRahul Shubhra Mandal and Santasabuj DasSynthetic Solutions to Drug ResistanceGunjan Arora, Richa Misra, and Andaleeb SajidFuture of drug discoveryAhmed Kamal, Shalini Nekkanti, Nagula Shankaraiah, Manda Sathish

Erscheint lt. Verlag 21.3.2017
Zusatzinfo XIV, 630 p. 64 illus., 49 illus. in color.
Verlagsort Cham
Sprache englisch
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Pharmazie
Naturwissenschaften Biologie Mikrobiologie / Immunologie
Technik
Schlagworte antibacterial drug resistance • Antibiotics • Cancer • drug discovery • drug resistance • immune system
ISBN-10 3-319-48683-7 / 3319486837
ISBN-13 978-3-319-48683-3 / 9783319486833
Haben Sie eine Frage zum Produkt?
PDFPDF (Wasserzeichen)
Größe: 11,1 MB

DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasser­zeichen und ist damit für Sie persona­lisiert. Bei einer missbräuch­lichen Weiter­gabe des eBooks an Dritte ist eine Rück­ver­folgung an die Quelle möglich.

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Entstehung, Progression und Therapie von Krebs

von Christoph Wagener; Oliver Müller

eBook Download (2022)
Thieme (Verlag)
199,99
Entstehung, Progression und Therapie von Krebs

von Christoph Wagener; Oliver Müller

eBook Download (2022)
Thieme (Verlag)
199,99
Handbuch für die Pflegepraxis

von Thomas Kroner; Anita Margulies; Sacha Rothschild …

eBook Download (2023)
Springer Berlin Heidelberg (Verlag)
29,99